Abstract
This IRB-approved retrospective study reviewed patient-reported outcomes following Wharton’s Jelly (WJ) birth tissue allograft applications in 38 individuals experiencing sacroiliac (SI) joint–related discomfort after conservative care.
Methods
Patients were followed for 90 days using the Numeric Pain Rating Scale (NPRS) and the WOMAC index, measuring pain, stiffness, and functional movement. Each participant received a single WJ allograft application with standardized follow-up.
Results
No adverse events or reactions were reported. Statistically significant improvements were observed in both NPRS and WOMAC scores by Day 90, reflecting reductions in reported discomfort and improvements in functional measures for the SI joint region.
Conclusion
These observational findings support continued research into Wharton’s Jelly allografts as a potential supplemental option for patients with SI joint–related symptoms who do not experience adequate progress with conservative management.